Evaluation of peripheral blood involvement of mantle cell lymphoma by fluorescence in situ hybridization in comparison with immunophenotypic and morphologic findings

Modern Pathology

Volumn 17, Issue 5, 2004, Pages 553-560

  Gu, Jun ^a   Huh, Yang O ^a   Jiang, Feng ^a   Caraway, Nancy P ^a   Romaguera, Jorge E ^a   Zaidi, Tanweer M ^a   Fernandez, Ricardo L ^a   Zhang, Huazhong ^a   Khouri, Issa F ^a   Katz, Ruth L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cytomorphology; Flow cytometry; Immunophenotyping; Interphase fluorescence in situ hybridization; Mantle cell lymphoma; Peripheral blood

Indexed keywords

CD19 ANTIGEN; CD5 ANTIGEN; CYCLIN D1; HYBRID PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN;

ARTICLE; BONE MARROW CELL; CELL STRUCTURE; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 13; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOMA CELL; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SIGNAL DETECTION; UNITED STATES;

ANTIGENS, CD19; ANTIGENS, CD5; CYCLIN D1; FLOW CYTOMETRY; IMMUNOGLOBULIN G; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; LYMPHOMA, MANTLE-CELL; REPRODUCIBILITY OF RESULTS;

EID: 3042845274     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800068     Document Type: Article

References (21)

1. Zukerberg LR, Medeiros LJ, Ferry JA, et al. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 1993;100:373-385.
2. Caligaris-Cappio F, Gobbi M, Bofill M, et al. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med 1982;155:623-628.
3. Abe M, Tominaga K, Wakasa H. Phenotypic characterization of human B-lymphocyte subpopulations, particularly human CD5+ B-lymphocyte subpopulation within the mantle zones of secondary follicles. Leukemia 1994;8:1039-1044.
4. Dorfman DM, Pinkus GS. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Mod Pathol 1994;7:326-331.
5. Kilo MN, Dorfman DM. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. Am J Clin Pathol 1996;105:451-457.
6. Kumar S, Green GA, Teruya-Feldstein J, et al. Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocyte lymphoma and mantle cell lymphoma. Mod Pathol 1996;9:925-929.
7. Dunphy CH, Wheaton SE, Perkins SL. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma. Mod Pathol 1997;10:818-822.
8. Medeiros LJ, Van Krieken JH, Jaffe ES, et al. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood 1990;76:2086-2090.
9. Vandenberghe E, De Wolf-Peeters C, van den Oord J, et al. Translocation (11;14): a cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage. J Pathol 1991;163:13-18.
10. Williams ME, Westermann CD, Swerdlow SH. Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus. Blood 1990;76:1387-1391.
11. Yang WI, Zukerberg LR, Motokura T, et al. Cyclin D1(Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994;145:86-96.
12. Pittaluga S, Verhoef G, Criel A, et al. Prognostic significance of bone marrow trephine and peripheral blood smears in 55 patients with mantle cell lymphoma. Leuk Lymphoma 1996;21:115-125.
13. Singleton TP, Anderson MM, Ross CW, et al. Leukemic phase of mantle cell lymphoma, blastoid variant. Am J Clin Pathol 1999;111:495-500.
14. Viswanatha DS, Foucar K, Berry BR, et al. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma. Mod Pathol 2000;13: 825-833.
15. Wong KF, Chan JK, So JC, et al. Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders. Cancer 1999;86:850-857.
16. Bosch F, Lopez-Guillermo A, Campo E, et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 1998;82: 567-575.
17. Coiffier B. Which treatment for mantle-cell lymphoma patients in 1998? J Clin Oncol 1998;16:3-5.
18. Teodorovic I, Pittaluga S, Kluin-Nelemans JC, et al. Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol 1995;13:2819-2826.
19. Li JY, Gaillard F, Moreau A, et al. Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am J Pathol 1999;154:1449-1452.
20. Remstein ED, Kurtin PJ, Buno I, et al. Diagnostic utility of fluorescence in situ hybridization in mantle cell lymphoma. Br J Haematol 2000;110:856-862.
21. Frater JL, Tsiftsakis EK, Hsi ED, et al. Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential of lymphomas of small lymphocytes. Diagn Mol Pathol 2001;10:214-222.